Tommy Kenny
Consejero General en INTELGENX TECHNOLOGIES CORP. .
Fortuna: 27 931 $ al 30/04/2024
Perfil
Tommy Kenny has held multiple positions in the legal field.
He is currently the Vice President-Legal Affairs & General Counsel at Intelgenx Corp.
and has been in this role since 2021.
Prior to this, he served as the Senior Vice President & General Counsel at IntelGenx Technologies Corp.
starting in 2016.
Additionally, Mr. Kenny currently works as an Associate at Brouillette & Partners.
In terms of education, Mr. Kenny holds a graduate degree from the University of Sherbrooke and a undergraduate degree from Bishop's University.
He also obtained a graduate degree from the University of Montreal Law School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/01/2024 | 167 250 ( 0.10% ) | 27 931 $ | 30/04/2024 |
Cargos activos de Tommy Kenny
| Empresas | Cargo | Inicio |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Consejero General | 01/01/2016 |
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Consejero General | 01/01/2021 |
| Brouillette & Partners | Corporate Officer/Principal | - |
Formación de Tommy Kenny.
| University of Montreal Law School | Graduate Degree |
| University of Sherbrooke | Graduate Degree |
| Bishop's University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
| Brouillette & Partners |
- Bolsa de valores
- Insiders
- Tommy Kenny
